French drugmaker Sanofi reported a fourth-quarter profit that came in-line with analysts' estimates on Thursday, and said it would buy back 5 billion euros ($5.21 billion) in shares this year as it ...

European equities traded in the US as American depositary receipts were treading water late Monday morning, edging 0.04% higher to 1,357.59 on the S&P Europe Select ADR Index. From continental Europe, ...

Judge José Luis Calama of the National Court, who is investigating the Grifols case, has asked the National Securities Market Commission ...

Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator ...

Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in court.

Are pharmaceutical companies earning too much? Deciding whether pharmaceutical companies earn too much money is complicated. In this issue of JAMA, 2 reports take different approaches to the question.

Grifols’ repository of PD plasma ... and for manufacturing pharmaceutical and diagnostic products. The company also supplies tools, information and services that enable hospitals, pharmacies ...

and for manufacturing pharmaceutical and diagnostic products. The company also supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently ...

MADRID (Reuters) - U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical ...